Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotech In 2009 Budget
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - The Australian federal 2009-2010 budget announced May 12, delivered a mixed bag to pharmaceutical and biotech companies, with biotech companies praising the R&D tax credit and Big Pharma critical of cuts to the Pharmaceutical Benefits Scheme